230 related articles for article (PubMed ID: 20660298)
21. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
[TBL] [Abstract][Full Text] [Related]
22. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.
Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q
Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322
[TBL] [Abstract][Full Text] [Related]
23. Genetic mosaics reveal both cell-autonomous and cell-nonautonomous function of murine p27Kip1.
Chien WM; Rabin S; Macias E; Miliani de Marval PL; Garrison K; Orthel J; Rodriguez-Puebla M; Fero ML
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4122-7. PubMed ID: 16537495
[TBL] [Abstract][Full Text] [Related]
24. Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor.
Liu NA; Jiang H; Ben-Shlomo A; Wawrowsky K; Fan XM; Lin S; Melmed S
Proc Natl Acad Sci U S A; 2011 May; 108(20):8414-9. PubMed ID: 21536883
[TBL] [Abstract][Full Text] [Related]
25. MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity.
McArthur GA; Foley KP; Fero ML; Walkley CR; Deans AJ; Roberts JM; Eisenman RN
Mol Cell Biol; 2002 May; 22(9):3014-23. PubMed ID: 11940659
[TBL] [Abstract][Full Text] [Related]
26. Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.
Berton S; Pellizzari I; Fabris L; D'Andrea S; Segatto I; Canzonieri V; Marconi D; Schiappacassi M; Benevol S; Gattei V; Colombatti A; Belletti B; Baldassarre G
Cell Cycle; 2014; 13(19):3100-11. PubMed ID: 25486569
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of galectin-3 in pituitary tumors.
Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
[TBL] [Abstract][Full Text] [Related]
28. p27(Kip1), a double-edged sword in Shh-mediated medulloblastoma: Tumor accelerator and suppressor.
Bhatia B; Malik A; Fernandez-L A; Kenney AM
Cell Cycle; 2010 Nov; 9(21):4307-14. PubMed ID: 21051932
[TBL] [Abstract][Full Text] [Related]
29. Pituitary hyperplasia in glycoprotein hormone alpha subunit-, p18(INK4C)-, and p27(kip-1)-null mice: analysis of proteins influencing p27(kip-1) ubiquitin degradation.
Lloyd RV; Ruebel KH; Zhang S; Jin L
Am J Pathol; 2002 Mar; 160(3):1171-9. PubMed ID: 11891212
[TBL] [Abstract][Full Text] [Related]
30. Cdc2-cyclin E complexes regulate the G1/S phase transition.
Aleem E; Kiyokawa H; Kaldis P
Nat Cell Biol; 2005 Aug; 7(8):831-6. PubMed ID: 16007079
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
[TBL] [Abstract][Full Text] [Related]
32. Expression of Cyclin E/Cdk2/p27
Dong W; Zhu H; Gao H; Shi W; Zhang Y; Wang H; Li C; Song G; Zhang Y
World Neurosurg; 2019 Jan; 121():e45-e53. PubMed ID: 30196178
[TBL] [Abstract][Full Text] [Related]
33. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
34. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.
Geisen C; Karsunky H; Yücel R; Möröy T
Oncogene; 2003 Mar; 22(11):1724-9. PubMed ID: 12642875
[TBL] [Abstract][Full Text] [Related]
35. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
36. Concerning the article "Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia".
Saeger W
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):68. PubMed ID: 20127571
[No Abstract] [Full Text] [Related]
37. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
38. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
39. Lycopene and beta-carotene induce growth inhibition and proapoptotic effects on ACTH-secreting pituitary adenoma cells.
Haddad NF; Teodoro AJ; Leite de Oliveira F; Soares N; de Mattos RM; Hecht F; Dezonne RS; Vairo L; Goldenberg RC; Gomes FC; de Carvalho DP; Gadelha MR; Nasciutti LE; Miranda-Alves L
PLoS One; 2013; 8(5):e62773. PubMed ID: 23667519
[TBL] [Abstract][Full Text] [Related]
40. Role of the high mobility group A proteins in the regulation of pituitary cell cycle.
Fedele M; Fusco A
J Mol Endocrinol; 2010 Jun; 44(6):309-18. PubMed ID: 20219853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
